Luma locks down 15-year, $410M fund for life science investments September 9, 2026Posted inBiotechnology Luma Group announced the final close of its inaugural life sciences venture capital fund totaling $410 million. Post navigation Previous Post GV-backed Encoded gains $275M to advance Dravet drug, scale genetic med manufacturingNext PostGalaxamide protects mouse uterus from cisplatin injury via anti-inflammatory effects
